hero section gradient
19 handpicked stocks

Powering The AI Gold Rush

OpenAI's recent secondary stock sale, valuing the company at a record $500 billion, highlights the massive investor confidence pouring into the artificial intelligence sector. This surge in capital creates a significant opportunity for companies that provide the critical infrastructure and hardware powering the AI revolution.

Author avatar

Han Tan | Market Analyst

Published on August 17

Your Basket's Financial Footprint

Interpretation of the basket's market capitalisation and investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance implies lower volatility and broader market-like behaviour, so returns are likely steadier, not explosive.
  • Treat as a core holding for diversified portfolios, not a speculative, concentrated growth play.
  • Expect steady long-term appreciation rather than short-term explosive gains; growth may be moderate.
Total Market Cap
  • NVDA: $4.40T

  • TSM: $1.23T

  • ASML: $400.56B

  • Other

About This Group of Stocks

1

Our Expert Thinking

OpenAI's record $500 billion valuation signals massive capital flowing into AI. This creates huge demand for the infrastructure companies that power AI development - the 'picks and shovels' of the AI revolution. We've selected companies providing essential semiconductors, data centres, and networking hardware.

2

What You Need to Know

This group focuses on infrastructure rather than AI software companies. These are the foundational suppliers that benefit as AI leaders expand. Think semiconductor manufacturers, data centre operators, and hardware providers - the backbone that makes AI possible.

3

Why These Stocks

Each company was handpicked by professional analysts as a critical enabler of AI growth. As billions pour into AI development, these infrastructure providers are positioned to capture significant demand for computational power, storage, and connectivity.

Why You'll Want to Watch These Stocks

🚀

Riding The $500B Wave

OpenAI's massive valuation shows where the smart money is going. These infrastructure companies are positioned to capture the surge in demand as AI spending explodes across the industry.

The Power Behind The Power

Every AI breakthrough needs serious computing muscle. These are the companies providing the chips, data centres, and networks that make AI magic happen - and they're essential for every major player.

💎

Gold Rush Infrastructure Play

In every gold rush, the smart money was on selling picks and shovels. These companies are the modern equivalent - providing the essential tools that every AI company desperately needs.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions